| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP & Chief Hro | SVP & CHRO | SVP, Global Human Resources
3 companies
Jacqueline Scanlan is Executive VP & Chief Hro at FMC, with reported holdings spanning 3 companies. Jacqueline Scanlan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
Our model assigns Jacqueline Scanlan a middling insider score of 55/100, based on 7 past trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of +25.2%.
Jacqueline Scanlan's largest disclosed position is in HAE as SVP, Global Human Resources, worth about $507K. The HAE filings lean toward selling, a net 36,542 shares.
Jacqueline Scanlan has 41 Form 4 filings on record from March 2018 to September 2026, across 3 companies: Executive VP & Chief Hro at FMC (FMC), 2023–2026; SVP & CHRO at Axalta Coating Systems (AXTA), 2021–2023; SVP, Global Human Resources at Haemonetics (HAE), 2018–2021.
The 77 reported transactions were 35 open-market sales, 12 option exercises, 11 stock awards and 10 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 23 sales worth about $4.7M.
The largest open-market sale was 15,402 shares of HAE at an average $90.02 on June 16, 2020, about $1.4M.
3 of the 4 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | FMC Fmc Corp | Executive VP & Chief Hro | Sell10b5-1 | 3,790 | $34.00 | $128,860.00 | -10.3% | -58.7% | -72.9% | |
| Aug 18, 2025 | FMC Fmc Corp | Executive VP & Chief Hro | Sell10b5-1 | 1,510 | $37.49 | $56,609.90 | -3.9% | -65.9% | -73.3% | |
| Nov 11, 2024 | FMC Fmc Corp | Executive VP & Chief Hro | Sell10b5-1 | 4,529 | $59.67 | $270,245.43 | -13.7% | -39.9% | -75.8% | |
| Aug 9, 2023 | AXTA Axalta Coating Systems Ltd. | SVP & CHRO | Sell | 17,008 | $29.48 | $501,395.84 | -81.0% | +0.3% | +17.0% | |
| Jun 7, 2021 | HAE Haemonetics Corp | SVP, Global Human Resources | Sell | 195 | $55.09 | $10,742.55 | -4.4% | +14.3% | +17.1% | |
| May 19, 2021 | HAE Haemonetics Corp | SVP, Global Human Resources | Sell | 112 | $55.19 | $6,181.28 | -2.5% | +4.9% | +6.5% | |
| May 17, 2021 | HAE Haemonetics Corp | SVP, Global Human Resources | Sell | 102 | $55.97 | $5,708.94 | -2.2% | +3.1% | +5.1% | |
| Mar 8, 2021 | HAE Haemonetics Corp | SVP, Global Human Resources | Sell | 107 | $120.07 | $12,847.49 | -2.4% | - | - | |
| Jun 16, 2020 | HAE Haemonetics Corp | SVP, Global Human Resources | Sale+OE | 15,402 | $90.02 | $1,386,495.83 | -77.4% | - | - | |
| Jun 8, 2020 | HAE Haemonetics Corp | SVP, Global Human Resources | Sell | 324 | $97.03 | $31,437.72 | -5.4% | - | - |